RecruitingNCT06523647

Clinical Efficacy of Ustekinumab in Crohn's Disease

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components

Sponsor

Kazakhstan Scientific Society for Study of intestine diseases

Enrollment

150 participants

Start Date

Jun 27, 2023

Study Type

OBSERVATIONAL

Conditions

Clinical Efficacy of Ustekinumab in Crohn's Disease: an Observational Study With Retrospective and Prospective Components.

Min Age: 18 Years

Patients aged 18 years and older;
Patients who were first prescribed Ustekinumab between January 1 and December 31, 2024
Patients who provided written informed consent to participate in the study

Contraindications to the use of the drug Ustekinumab per the current instructions:
Clinically significant active infection (active tuberculosis, active viral hepatitis);
Pregnancy and lactation;
A history of clinically significant, in the opinion of the investigator, psychiatric disorders that may interfere with the study procedures and compliance with the drug regimen;
Ulcerative colitis;
Malignant gastrointestinal diseases in history or at the time of inclusion in the study;
Decompensated chronic diseases of the liver, kidneys, cardiovascular system, systemic vasculitis, diabetes mellitus;
Abuse of alcohol or psychoactive drugs within 1 year before the start of this study (as reported by the patient);
Participation in an interventional clinical trial.

NJSC "West Kazakhstan Marat Ospanov Medical University"

Aktobe, Kazakhstan

Non-Profit Joint Stock Company "Kazakh National Medical University named after S.D. Asfendiyarov"

Almaty, Kazakhstan

State-owned public enterprise with the right of economic management "Multidisciplinary City Hospital No. 1" of the Akimat of Astana

Astana, Kazakhstan

State-owned public enterprise with the right of economic management "Regional Clinical Hospital" of the Health Department of the Turkestan Region

Shymkent, Kazakhstan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06523647